Red, you are correct. They are not toxic lending. In the land of OTC, it is normal for a company to set a large AS in order to fund the business, while the company grows it. However, in the case of BigT, they have already demonstrated that they have a paying product. Anyone can look at the latest 10K to confirm this fact. I believe we are getting close too with the ticker change.